Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)

Life Sciences Report

View as an RSS Feed
  • Position Yourself For Big Returns In The Stem Cell Space: Jason Kolbert
    on Mon, May 13 • MBLTY.PK, TEVA, DNDN • 4 Comments
  • 6 Superstars For Your Biotech Portfolio: John McCamant
    on Fri, May 10 • ALKS, ISIS, SGMO • 1 Comment
  • Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
    on Fri, May 3 • VRTX, PCYC, NVS • 3 Comments
  • What Will It Take For Stem Cell Companies To Close The Valuation Gap?
    on Wed, Apr 17 • MBLTY.PK, SNN, SHPG • 1 Comment
  • Companies That Can Mend The Biotech Market: Stephen Brozak
    on Fri, Apr 12 • ASTM, CYTX, BTX • 7 Comments
  • Biotechs With Staggering Potential: Grant Zeng
    on Fri, Apr 5 • ATOS, TKMR, BMY • 5 Comments
  • Several Big Growth Stories In Biotech: Keith Markey
    on Thu, Mar 28 • MNKD, NKTR, LGND • 5 Comments
  • Solving The R&D Investment Dilemma With Project Funding: Mark Kessel
    on Sun, Mar 24 • ISIS, EXEL, ALXA • 1 Comment
  • The Stem Cell Revolution Can Jump Start Your Portfolio: Jason Kolbert
    on Fri, Mar 15 • VRTX, GILD, ACHN • 16 Comments
  • George Zavoico: Biotech Stocks That Deserve A Closer Look
    on Fri, Mar 8 • NVAX, ACAD, PPHM • 1 Comment
  • What Will Boost Medtech Stocks? Look For A Better Mousetrap, Says William Plovanic
    on Fri, Feb 22 • DXCM, PODD, NUVA • Comment!
  • Ram Selvaraju: Fall In Love With These Biotech Stocks
    on Thu, Feb 14 • TSRX, PFE, IRWD • 1 Comment
  • 8 Biotech Growth Names: Greg Wade
    on Fri, Feb 8 • ECYT, PCYC, INSM • 3 Comments
  • Stephen Brozak: Changing The Way Money Is Made And Diseases Are Cured
    on Fri, Jan 25 • AMGN, CELG, CYTX • 3 Comments
  • Anything For A Buck: Jim Letourneau Looks To Canadian Biotech For Opportunity
    on Fri, Jan 18 • YMI, VRSEF.PK, ACST • 6 Comments
  • Which Companies Are In Michael King's Oncology Wheelhouse?
    on Sat, Jan 12 • GEVA, SRPT, ONXX • 2 Comments
  • Josh Levine Names His Biotech Game-Changers
    on Fri, Jan 4 • INO • 12 Comments
  • 4 Biotech Names With Major Market Potential: Michael Higgins
    on Thu, Dec 20, 2012 • BDSI, ENDP, MNKD • 5 Comments
  • Do You Have The Guts To Take On Cutting-Edge Biotech Like This VC?
    on Fri, Dec 14, 2012 • MYLGF.PK, NVLT.OB, TTNP.OB • 5 Comments
  • Testing, Testing: Analyst Kevin DeGeeter On 5 Good Bets In Cancer Diagnostics
    on Fri, Nov 30, 2012 • MYGN, DGX, NAVB • 1 Comment
  • Lessons From The Liver Meeting: Sagient's John Tucker Names Companies That Could Reignite The Hepatitis C Industry
    on Fri, Nov 30, 2012 • VRTX, GILD, MVRBF.PK • 3 Comments
  • Applying The Venture Capital Model To Public Companies: Hugh Cleland
    on Wed, Nov 21, 2012 • SUPN, NEPT, ACST • 2 Comments
  • Michael Berry Applies His 10 Discovery Investing Factors To Biotech
    on Wed, Nov 21, 2012 • CELG • Comment!
  • Analyst Scott Power Finds The Upside In Biotech Down Under
    on Thu, Nov 8, 2012 • SSH, HTWR, THOR • Comment!
  • A Capital-Efficient Prescription For New Drugs: Raghuram 'Ram' Selvaraju
    on Thu, Nov 1, 2012 • BLRX, AMPE, SGYP • 3 Comments
  • Out Of The Red And Into The Black: John McCamant On Investment In Blood Cancer Companies
    on Thu, Oct 25, 2012 • CELG, RHHBY.OB, PCYC • Comment!
  • What Moves Biotech Stocks? Ed Arce Has Answers
    on Thu, Oct 18, 2012 • LGND, SVNT, BCRX • Comment!
  • Casey Analyst Forecasts Explosive Biotech Growth
    on Thu, Oct 11, 2012 • SNN, SYK, NXTM • Comment!
  • Pick Biotech Winners Like A Pro: John McCamant
    on Fri, Oct 5, 2012 • IBB, PCYC, CNDO • 2 Comments
  • Can Stem Cells Regenerate Your Portfolio? Stephen Dunn Says Yes
    on Fri, Sep 28, 2012 • DNDN, NBS, PFE • 5 Comments
  • ThinkEquity Analyst Bets On Extraordinary Science And Clinical Data
    on Thu, Sep 20, 2012 • BMRN, GSK, PFE • Comment!
  • 7 Innovative Biotechs That Could Soar By Year-End: George Zavoico
    on Thu, Sep 13, 2012 • AGEN, PPHM, ARQL • 1 Comment